battle of glp 1 delivery technologies Oral GLP-1 peptide using recombinant Lactobacillus gasseri for the treatment of type 2 diabetes mellitus Pharma Giants Bet on Next-Generation
Description
While some people find their digestion speeds up initially, others may experience a slowdown that leads to discomfort or bloating
Unlike the steatosis, clinical results about existing fibrosis are not satisfactory
Europe GLP-1 Agonists Weight Loss Drugs Market Estimates and Forecasts, 2018-2030 (USD Million) 7.3.2
For someone starting at 300 pounds, the gap widens even further
Its also a snapshot of the evolving market for GLP-1s, as health services and pharmacy companies look to capitalize on not only providing access to the drugs, but creating services around them
